Indian Journal of Endocrinology and Metabolism

Efficacy of Dapagliflozin vs. Saroglitazar on Hepatic Steatosis and Fibrosis in Patients of Type 2 Diabetes Mellitus and Metabolic-Associated Steatotic Liver Disease (MASLD)

By Bijay K. Das, Sambit Das, Dayanidhi Meher, Vishal Agarwal

Randomised trial in 101 peopleInterventions

6 months

The paper

Bijay K. Das, Sambit Das, Dayanidhi Meher, Vishal Agarwal

Kalinga Institute of Medical Sciences

Indian Journal of Endocrinology and Metabolism, 1 Jul 2026, CC BY-NC-SA

doi.org/10.4103/ijem.ijem_848_25 PubMed 42787830

Journal of Science and Medicine in Sport8 Oct 2026
Bands reduced liver fat in postmenopausal women with MASLD
Journal of Cachexia, Sarcopenia and Muscle5 Oct 2026
A 5:2 fasting regimen curbs muscle impairment in mice
Medicine10 Oct 2026
Cholesterol-inflammation index linked to higher diabetes risk
Nature Metabolism2 Oct 2026
Dasatinib and quercetin reduce liver fibrosis in a phase-2 MASH trial